Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
EPS (Diluted)
Bristol-Myers Squibb Co
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bristol-Myers Squibb Co
NYSE:BMY
|
EPS (Diluted)
-$3
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
EPS (Diluted)
$15
|
CAGR 3-Years
41%
|
CAGR 5-Years
24%
|
CAGR 10-Years
12%
|
|
Pfizer Inc
NYSE:PFE
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
EPS (Diluted)
$0
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-5%
|
|
Zoetis Inc
NYSE:ZTS
|
EPS (Diluted)
$5
|
CAGR 3-Years
14%
|
CAGR 5-Years
12%
|
CAGR 10-Years
18%
|
|
Eli Lilly and Co
NYSE:LLY
|
EPS (Diluted)
$6
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
See Also
What is Bristol-Myers Squibb Co's EPS (Diluted)?
EPS (Diluted)
-3
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's EPS (Diluted) amounts to -3 USD.
What is Bristol-Myers Squibb Co's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-3%
The average annual EPS (Diluted) growth rates for Bristol-Myers Squibb Co have been -3% over the past three years .